LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-30-MONTH DATA FROM THE RELIANCE REGISTRY

被引:0
|
作者
Kuemmerle-Deschner, J. B. [1 ]
Kortus-Goetze, B. [2 ]
Oommen, P. [3 ]
Janda, A. [4 ]
Rech, J. [5 ,6 ]
Kallinich, T. [7 ]
Weller-Heinemann, F. [8 ]
Horneff, G. [9 ]
Foeldvari, I. [10 ]
Schuetz, C. [11 ]
Borte, M. [12 ]
Braner, A. [13 ]
Weber-Arden, J. [14 ]
Blank, N. [15 ]
机构
[1] Univ Hosp Tuebingen, Div Pediat Rheumatol, Dept Pediat, Tubingen, Germany
[2] Univ Marburg, Div Nephrol, Marburg, Germany
[3] Heinrich Heine Univ Dusseldorf, Clin Pediat Hematol Oncol & Clin Immunol, Dusseldorf, Germany
[4] Univ Hosp Ulm, Dept Pediat, Ulm, Germany
[5] Friedrich Alexander Univ FAU, Erlangen, Germany
[6] Erlangen Nurnberg & Univ Erlangen, Dept Internal Med 3, Rheumatol & Immunol, Erlangen, Germany
[7] Charite Univ Med Berlin, Dept Pediat, Div Pulmonol Immunol & Crit Care Med, Berlin, Germany
[8] Klinikum Bremen Mitte, Hess Kinderklin, Bremen, Germany
[9] Asklepios Clin Sankt Augustin, St Augustin, Germany
[10] Ctr Pediat & Adolescence Rheumatol, Hamburg, Germany
[11] Tech Univ Dresden, Pediat, Med Fak Carl Gustav Carus, Dresden, Germany
[12] Hosp St Georg GmbH Leipzig, Immuno Deficiency Ctr Leipzig IDCL, Leipzig, Germany
[13] Univ Hosp Frankfurt, Dept Med 2, Rheumatol, Frankfurt, Germany
[14] Novartis Pharma GmbH, Nurnberg, Germany
[15] Univ Heidelberg Hosp, Rheumatol, Heidelberg, Germany
关键词
D O I
10.1136/annrheumdis-2021-eular.3716
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OP0092
引用
收藏
页码:50 / 51
页数:2
相关论文
共 50 条
  • [41] Long-term renal outcome of Cryopyrin-associated periodic syndrome (CAPS) under anti-Interleukin-1 therapy
    Russwurm, Martin
    Johannsen, Sophia
    Kortus-Goetze, Birgit
    Haas, Christian S.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [42] Long-term, limiting impact of cryopyrin-associated periodic syndrome (CAPS) on patients' lives: Results from a comprehensive patient research survey
    Stych, B.
    Hoffmann, H. M.
    Dobrovolny, D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S107 - S107
  • [43] Vaccination in Patients with Autoinflammatory Periodic Syndromes Under Canakinumab - Safety Data Interim Analysis of the RELIANCE Registry
    Kuemmerle-Deschner, Jasmin B.
    Henes, Joerg
    Kortus-Goetze, Birgit
    Kallinich, Tilmann
    Oommen, Prasad T.
    Rech, Juergen
    Krickau, Tobias
    Weller-Heinemann, Frank
    Horneff, Gerd
    Janda, Ales
    Foeldvari, Ivan
    Schuetz, Catharina
    Dressler, Frank
    Borte, Michael
    Hufnagel, Markus
    Meier, Florian
    Fiene, Michael
    Weber-Arden, Julia
    Blank, Norbert
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3638 - 3640
  • [44] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH AUTOINFLAMMATORY PERIODIC FEVER SYNDROMES - FIRST INTERIM ANALYSIS OF THE FMF/TRAPS/HIDS SUBGROUPS FROM THE RELIANCE REGISTRY
    Henes, J.
    Kuemmerle-Deschner, J. B.
    Borte, M.
    Foeldvari, I.
    Horneff, G.
    Kallinich, T.
    Kortus-Goetze, B.
    Weller-Heinemann, F.
    Weber-Arden, J.
    Blank, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 837 - 837
  • [45] Canakinumab in Patients with Tumor Necrosis Factor Receptor-associated Periodic Syndrome (TRAPS) - Long-term Efficacy and Safety Data from a RELIANCE Registry Interim Analysis
    Blank, Norbert
    Schuetz, Catharina
    Henes, Joerg
    Kallinich, Tilmann
    Oommen, Prasad T.
    Borte, Michael
    Hufnagel, Markus
    Janda, Ales
    Weber-Arden, Julia
    Kuemmerle-Deschner, Jasmin B.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1614 - 1616
  • [46] LONG-TERM SAFETY OF CANAKINUMAB IN PATIENTS WITH AUTOINFLAMMATORY DISEASES - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Kuemmerle-Deschner, J. B.
    Henes, J.
    Kortus-Goetze, B.
    Kallinich, T.
    Oommen, P.
    Rech, J.
    Krickau, T.
    Weller-Heinemann, F.
    Horneff, G.
    Janda, A.
    Foeldvari, I.
    Schuetz, C.
    Dressler, F.
    Borte, M.
    Hufnagel, M.
    Meier, F.
    Fiene, M.
    Weber-Arden, J.
    Blank, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1026 - 1027
  • [47] EFFECT OF LONG-TERM TREATMENT WITH ANAKINRA (KINERET®) ON BONE MINERAL DENSITY IN PATIENTS WITH SEVERE CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES
    Timdahl, K.
    Goldbach-Mansky, R.
    Leinonen, M.
    Olivecrona, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 386 - 386
  • [48] Long-Term Efficacy of Anakinra in Cryopyrin-Associated Periodic Syndrome: Focus on Destructive Arthropathy
    Kim, Young Ho
    Kim, Bong Jik
    Han, Jinhee
    Choi, Byung Yoon
    Lee, Soyoung
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (08) : 1936 - 1939
  • [49] Long-Term Efficacy of Anakinra in Cryopyrin-Associated Periodic Syndrome: Focus on Destructive Arthropathy
    Young Ho Kim
    Bong Jik Kim
    Jinhee Han
    Byung Yoon Choi
    Soyoung Lee
    Journal of Clinical Immunology, 2021, 41 : 1936 - 1939
  • [50] Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey
    Miyamoto, Takayuki
    Izawa, Kazushi
    Masui, Sho
    Yamazaki, Atsue
    Yamasaki, Yuichi
    Matsubayashi, Tadashi
    Shiraki, Mayuka
    Ohnishi, Hidenori
    Yasumura, Junko
    Kawabe, Tomohiro
    Miyamae, Takako
    Matsubara, Tomoyo
    Arakawa, Naoya
    Ishige, Takashi
    Takizawa, Takumi
    Shimbo, Asami
    Shimizu, Masaki
    Kimura, Naoki
    Maeda, Yuichi
    Maruyama, Yuta
    Shigemura, Tomonari
    Furuta, Junichi
    Sato, Satoshi
    Tanaka, Hiroshi
    Izumikawa, Miharu
    Yamamura, Masahiro
    Hasegawa, Toshio
    Kaneko, Hiroshi
    Nakagishi, Yasuo
    Nakano, Naoko
    Iida, Yasunori
    Nakamura, Tamaki
    Wakiguchi, Hiroyuki
    Hoshina, Takayuki
    Kawai, Toshinao
    Murakami, Kosaku
    Akizuki, Shuji
    Morinobu, Akio
    Ohmura, Koichiro
    Eguchi, Katsuhide
    Sonoda, Motoshi
    Ishimura, Masataka
    Furuno, Kenji
    Kashiwado, Momoko
    Mori, Masaaki
    Kawahata, Kimito
    Hayama, Koremasa
    Shimoyama, Kumiko
    Sasaki, Natsuko
    Ito, Taisuke
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (06) : 949 - 962